Atlas Trials

Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants

Clinical trial NCT01444781 · COMPLETED

Trial details

NCT number
NCT01444781
Sponsor
Sanofi Pasteur, a Sanofi Company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
DiphtheriaTetanusWhooping CoughHepatitis BPoliomyelitis
Start date
2011-09-01
Primary completion
2013-04-01
Enrollment
1106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.